Denali Therapeutics Inc. DNLI Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s software and technology licenses, net?
- Denali Therapeutics Inc. (DNLI) reported software and technology licenses, net of $26.22M in Q1 2026.
- How has Denali Therapeutics Inc.'s software and technology licenses, net changed year-over-year?
- Denali Therapeutics Inc.'s software and technology licenses, net decreased by 2.7% year-over-year, from $26.93M to $26.22M.
- What is the long-term trend for Denali Therapeutics Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s software and technology licenses, net has grown at a 60.2% compound annual growth rate (CAGR), from $2.46M to $25.94M.